Alice Bessey

All publications

Journal articles

• Essat M, Cooper K, Bessey A, Clowes M, Chilcott JB & Hunter KD (2022) Diagnostic accuracy of conventional oral examination for detecting oral cavity cancer and potentially malignant disorders in patients with clinically evident oral lesions: Systematic review and meta‐analysis. Head & Neck. View this article in WRRO
• Bessey A, Chilcott J, Pandor A & Paisley S (2020) The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism. International Journal of Neonatal Screening, 6(4). View this article in WRRO
• Bessey A, Chilcott J, Leaviss J, de la Cruz C & Wong R (2019) A cost-effectiveness analysis of newborn screening for severe combined immunodeficiency in the UK. International Journal of Neonatal Screening, 5(3). View this article in WRRO
• Harnan S, Tappenden P, Cooper K, Stevens J, Bessey A, Rafia R, Ward S, Wong R, Stein RC & Brown J (2019) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health Technology Assessment, 23(30). View this article in WRRO
• Bessey A, Chilcott JB, Leaviss J & Sutton A (2018) Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.. Orphanet J Rare Dis, 13(1), 179-179. View this article in WRRO
• Morrell CJ, Sutcliffe P, Booth A, Stevens J, Scope A, Stevenson M, Harvey R, Bessey A, Cantrell A, Dennis C-L , Ren S et al (2016) A systematic review, evidence synthesis and meta-analysis of quantitative and qualitative studies evaluating the clinical effectiveness, the cost-effectiveness, safety and acceptability of interventions to prevent postnatal depression. Health Technology Assessment, 20(37), 1-414. View this article in WRRO
• Essat M, Tappenden P, Ren S, Bessey A, Archer R, Wong R, Lobo A & Hoque S (2016) Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 34(3), 245-257. View this article in WRRO
• Rathbone J, Kaltenthaler E, Richards A, Tappenden P, Bessey A & Cantrell A (2013) A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS).. BMJ Open, 3(11), e003573. View this article in WRRO
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy. International Journal of Neonatal Screening, 10(3), 56-56.
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy. International Journal of Neonatal Screening, 10(3), 49-49.

Conference proceedings papers

• Bessey A, Leaviss J, de la Cruz GC, Chilcott J & Wong R (2017) THE COST-EFFECTIVENESS OF SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID) IN THE UK NHS NEWBORN BLOODSPOT SCREENING PROGRAMME. VALUE IN HEALTH, Vol. 20(9) (pp A501-A501)
• Morrell J, Sutcliffe P, Stevenson M, Stevens J, Booth A, Scope A, Bessey A, Dennis C-L, Cantrell A, Barkham M , Churchill D et al (2015) Prevention of postnatal depression: a meta-analysis of interventions to prevent postnatal depression. Journal of Reproductive and Infant Psychology, Vol. 33(3) (pp E3-E4), 13 September 2016 - 14 September 2016. View this article in WRRO
• Bessey A, Chilcott J, Pandor A & Paisley S (2014) The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa Dehydrogenase Deficiency (Lchadd). Value in Health, Vol. 17(7) (pp A531-A531)
• Bessey A, Whyte S, Minton J & Chilcott J (2013) ECONOMIC EVALUATION OF AN ELECTRICAL IMPEDANCE SPECTROSCOPY (EIS) DEVICE USED AS AN ADJUNCT TO COLPOSCOPY. VALUE IN HEALTH, Vol. 16(7) (pp A407-A407)
• Kaltenthaler E, Rathbone J, Tappenden P, Bessey A & Cantrell A (2012) ISSUES IN THE SYSTEMATIC REVIEW OF DRUGS FOR RARE DISEASES: A CASE STUDY OF ECULIZUMAB FOR AHUS. VALUE IN HEALTH, Vol. 15(7) (pp A455-A455)

Posters

• Bessey A, Chilcott J, Paisley S & Pandor A The cost-effectiveness of expanding the NHS newborn bloodspot screening programme to include homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1), isovaleric acidaemia (IVA), and long-chain hydroxyl acyl-CoA dehydrogenase deficiency (LCHADD) (2014).
• Rathbone J, Kaltenthaler E, Tappenden P, Bessey A & Cantrell A Issues in the systematic review of drugs for rare diseases: A case study of Eculizumab for AHUS (2012).

Preprints

• Cooper K, Essat M, Clowes M, Chilcott J, Hunter K & Bessey A (2022) Diagnostic accuracy of biopsy versus full excision for diagnosis of oral cancer: A systematic review. View this article in WRRO